£1m deal triggers Liverpool trial of lung disease drug
Cheshire biotech Infex Therapeutics has awarded a £1m contract to a Swiss manufacturer to produce the new treatment for serious lung infections that will be trialled in Liverpool. Tony McDonough reports Clinical trials for a new drug…